INS and diabetes mellitus: Based on the findings that Imatinib can quickly reverse new onset diabetes [7], two possibilities likely exist: one is that Imatinib enhances insulin production by the limited number of residual β cells in new-onset diabetic mice; the other is that Imatinib improves the sensitivity of peripheral tissues to insulin so that insufficient insulin would still be able to control blood glucose.